Advanced Molecular Detection (AMD) and Response to Infectious Disease Outbreaks

Advanced molecular detection (AMD) integrates the latest next-generation genomic sequencing technologies with bioinformatics and epidemiology expertise across CDC and the nation to help us find, track, and stop disease-causing pathogens faster than ever before.

SARS-CoV-2 Innovation: Broad Agency Announcement awards

Posted on Friday, July 2, 2021

The Centers for Disease Control and Prevention (CDC) has issued awards as part of the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance (SPHERES) Initiative. The awards are intended to fill knowledge gaps and promote innovation in the U.S. response to the COVID-19 pandemic.

Page last reviewed: July 2, 2021